QuidelOrtho
QDEL
£21.10
Share price
1.12%
Change (1 day)
-33.51%
Change (1 year)
Quidel is an American manufacturer of diagnostics testings that can be used to diagnose infectious diseases as well as cardiovascular and metabolic diseases.
QuidelOrtho (QDEL) - Total debt
Total debt on the balance sheet as of December 2024 : £2.01 Billion
According to QuidelOrtho's latest financial reports the company's total debt is £2.01 Billion. A company’s total debt is the sum of all current and non-current debts.
QuidelOrtho - Total debt on balance sheet (from 1996 to 2024)
Total debt by year
| Year | Total debt | Change |
|---|---|---|
| 2024-12-31 | £2.13 B | 4.13% |
| 2023-12-31 | £2.05 B | -12.87% |
| 2022-12-31 | £2.35 B | 2182.05% |
| 2021-12-31 | £0.10 B | 29.64% |
| 2020-12-31 | £79.6 M | -7.05% |
| 2019-12-31 | £85.63 M | 1.06% |
| 2018-12-31 | £84.74 M | -71.18% |
| 2017-12-31 | £0.29 B | 151.39% |
| 2016-12-31 | £0.11 B | 17.2% |
| 2015-12-31 | £99.81 M | 8.61% |
| 2014-12-31 | £91.9 M | 2623.1% |
| 2013-12-31 | £3.37 M | -50.17% |
| 2012-12-31 | £6.77 M | -78.85% |
| 2011-12-31 | £32.02 M | -38.25% |
| 2010-12-31 | £51.85 M | 1141.19% |
| 2009-12-31 | £4.17 M | -12.51% |
| 2008-12-31 | £4.77 M | 22.19% |
| 2007-12-31 | £3.9 M | -9.29% |
| 2006-12-31 | £4.3 M | -49.49% |
| 2005-12-31 | £8.53 M | 69.23% |
| 2004-12-31 | £5.04 M | -11.57% |
| 2003-12-31 | £5.69 M | -14.19% |
| 2002-12-31 | £6.64 M | -29.85% |
| 2001-12-31 | £9.46 M | -1.85% |
| 2000-12-31 | £9.64 M | |
| 1999-03-31 | £1.85 M | -2.66% |
| 1998-03-31 | £1.9 M | -7.66% |
| 1997-03-31 | £2.06 M | -31.5% |
| 1996-03-31 | £3.01 M |
Total debt for similar companies or competitors
| Company | Total debt/th> | differencediff. | Country |
|---|---|---|---|
 | £23.24 M | -98.85% | 🇺🇸 USA |
 | £14.08 B | 599.56% | 🇺🇸 USA |
 | £23.48 B | 1,066.37% | 🇺🇸 USA |
 | £10.96 M | -99.46% | 🇺🇸 USA |
 | £12.87 B | 539.44% | 🇺🇸 USA |
 | £3.38 B | 68.19% | 🇺🇸 USA |